cytisine has been researched along with Nicotine Addiction in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benowitz, NL; Blumenstein, B; Cain, D; Clarke, A; Jacobs, C; Leischow, S; Nides, M; Prochaska, J; Rigotti, NA | 1 |
| Allen, SI; Foulds, J; Yingst, J | 1 |
| Filipponi, A; Giordano, P; Giulietti, F; Iacoacci, C; Rosettani, G; Sarzani, R; Spannella, F | 1 |
| Barua, D; Boeckmann, M; Dogar, O; Elsey, H; Fatima, R; Gabe, R; Huque, R; Keding, A; Khan, A; Kotz, D; Kralikova, E; Li, J; Mansoor, S; Marshall, AM; Parrott, S; Readshaw, A; Sheikh, A; Siddiqi, K; Zahid, R | 1 |
| Benowitz, NL; Courtney, RJ; Tutka, P; Vinnikov, D | 1 |
| Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I | 1 |
| Cahill, K; Hartmann-Boyce, J; Lancaster, T; Stead, LF | 1 |
| Eibl, C; Guendisch, D; Mineur, YS; Papke, RL; Peng, C; Picciotto, MR; Stokes, C; Tian, C; Tomassoli, I | 1 |
| Cieślewicz, A; Jabłecka, A; Korzeniowska, K | 1 |
| Barnes, J; Bassett, B; Bullen, C; Glover, M; Howe, C; McRobbie, H; Nosa, V; Parag, V; Walker, N | 1 |
| Rigotti, NA | 1 |
| Bespalov, AY; Dravolina, OA; Radchenko, EV | 1 |
| Benowitz, NL; Prochaska, JJ | 1 |
| Bertrand, D; Bertrand, S; Coe, JW; Cremers, T; de Vries, M; Hurst, RS; Mather, RJ; O'Neill, BT; Rollema, H; Shrikhande, A; Tingley, FD; Tseng, E; Wang, EQ; Ward, KM; Williams, KE | 1 |
| Kobus, A | 1 |
| Braida, D; Clementi, F; Fasoli, F; Fucile, S; Gotti, C; Grady, SR; Loi, B; Manfredi, I; Marks, MJ; Pucci, L; Sala, M; Sparatore, F; Tasso, B; Wageman, CR; Zoli, M | 1 |
| Collins, AC; Deshpande, P; Labarca, C; Lester, HA; Marks, MJ; McKinney, SL; Nashmi, R; Schwarz, J; Tapper, AR; Whiteaker, P | 1 |
| Cedzynska, M; Tutka, P; West, R; Zatonski, W | 1 |
| Bessis, A; Champtiaux, N; Changeux, JP; Han, ZY; Marubio, L; McIntosh, JM; Rossi, FM; Zoli, M | 1 |
| Metelitsa, VI | 1 |
5 review(s) available for cytisine and Nicotine Addiction
| Article | Year |
|---|---|
Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
Topics: Alkaloids; Azocines; Bupropion; Clinical Decision-Making; Electronic Nicotine Delivery Systems; Humans; Quinolizines; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.
Topics: Alkaloids; Azocines; Clinical Trials as Topic; Humans; Quinolizines; Smoking Cessation; Tobacco Use Disorder | 2019 |
[Drugs used to treat nicotine addiction].
Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult | 2012 |
The Past, Present, and Future of Nicotine Addiction Therapy.
Topics: Alkaloids; Azocines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Policy; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Social Media; Text Messaging; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
[Simple therapeutic options in counteracting tobacco smoking].
Topics: Alkaloids; Azocines; Humans; Nicotine; Quinolizines; Smoking; Smoking Cessation; Tobacco Use Disorder | 2010 |
4 trial(s) available for cytisine and Nicotine Addiction
| Article | Year |
|---|---|
Cytisinicline for Smoking Cessation: A Randomized Clinical Trial.
Topics: Alkaloids; Azocines; Cigarette Smoking; Double-Blind Method; Duration of Therapy; Female; Humans; Male; Middle Aged; Nicotine; Quinolizidine Alkaloids; Quinolizines; Receptors, Nicotinic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome | 2023 |
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Topics: Adult; Alkaloids; Azocines; Bangladesh; Double-Blind Method; Female; Humans; Male; Middle Aged; Pakistan; Psychotherapy, Brief; Quinolizines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Tuberculosis | 2020 |
Cytisine versus nicotine for smoking cessation.
Topics: Adult; Alkaloids; Azocines; Female; Humans; Male; Middle Aged; Nausea; Nicotine; Quinolizines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2014 |
An uncontrolled trial of cytisine (Tabex) for smoking cessation.
Topics: Adult; Alkaloids; Azocines; Female; Humans; Male; Nicotine; Poland; Quinolizines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
11 other study(ies) available for cytisine and Nicotine Addiction
| Article | Year |
|---|---|
Cytisinicline to Speed Smoking Cessation in the United States.
Topics: Alkaloids; Azocines; Cigarette Smoking; Quinolizidine Alkaloids; Quinolizines; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Disorder; United States | 2023 |
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.
Topics: Alkaloids; Azocines; Behavior Therapy; Behavior, Addictive; Benzazepines; Humans; Meta-Analysis as Topic; Nicotinic Agonists; Quinolizines; Quinoxalines; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
Topics: Alkaloids; Animals; Azocines; Behavior, Animal; Benzazepines; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Drug Partial Agonism; HEK293 Cells; Humans; Male; Membrane Potentials; Mice; Molecular Structure; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline; Xenopus laevis | 2013 |
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia | 2013 |
Cytisine--a tobacco treatment hiding in plain sight.
Topics: Alkaloids; Azocines; Female; Humans; Male; Nicotine; Quinolizines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Agonist and antagonist effects of cytisine in vivo.
Topics: Alkaloids; Animals; Azocines; Discrimination, Psychological; Dose-Response Relationship, Drug; Electric Stimulation; Electrodes, Implanted; Male; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Rats, Wistar; Repetition Priming; Self Administration; Tobacco Use Disorder; Ventral Tegmental Area | 2015 |
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
Topics: Alkaloids; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Azepines; Azocines; Benzazepines; Brain; Dopamine; Heterocyclic Compounds, 4 or More Rings; Humans; Limbic System; Male; Mice; Mice, Knockout; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Tobacco Use Disorder; Varenicline; Xenopus laevis | 2010 |
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
Topics: Alkaloids; Animals; Azocines; Behavior, Animal; Drug Partial Agonism; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Motor Activity; Nicotine; Nicotinic Agonists; Protein Binding; Quinolizines; Rats; Rats, Wistar; Receptors, Nicotinic; Self Administration; Tobacco Use Cessation; Tobacco Use Disorder | 2013 |
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.
Topics: Alkaloids; Animals; Azocines; Brain; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cells, Cultured; Drug Tolerance; Leucine; Mice; Mice, Inbred C57BL; Motor Activity; Neurons; Nicotine; Point Mutation; Pyridines; Quinolizines; Receptors, Nicotinic; Reward; Serine; Tobacco Use Disorder; Up-Regulation | 2004 |
Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice.
Topics: Alkaloids; Animals; Autoradiography; Azocines; Binding Sites; Binding, Competitive; Brain; Bridged Bicyclo Compounds, Heterocyclic; Conotoxins; Corpus Striatum; Dopamine; Homozygote; Mice; Mice, Knockout; Mice, Mutant Strains; Nicotine; Nicotinic Antagonists; Organ Specificity; Protein Subunits; Pyridines; Quinolizines; Receptors, Nicotinic; Retinal Ganglion Cells; Tobacco Use Disorder; Visual Pathways | 2002 |
[Pharmacological agents in controlling smoking].
Topics: Alkaloids; Anabasine; Azocines; Chewing Gum; Drug Evaluation; Female; Humans; Male; Mouthwashes; Nicotiana; Nicotine; Plants, Toxic; Quinolizines; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1987 |